Navigation Links
Starpharma and Elanco Sign Agreement

MELBOURNE, Australia, May 11 /PRNewswire/ -- Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced the signing of a collaborative research, license and commercialisation agreement with Elanco, the animal health division of US pharmaceutical company Eli Lilly and Company.

The parties will collaborate to develop new animal health products with enhanced properties using Starpharma's dendrimer technology. Under the agreement, Starpharma will receive revenue from research fees, and is eligible for milestone payments and royalties on sale of any product developed. Elanco will receive exclusivity within the animal health field. Terms were not disclosed.

"We are very pleased to have secured such a strong animal health partner as Elanco for our delivery technology," said Dr Jackie Fairley, CEO, Starpharma.

"Their expertise, resources and market presence will be enormously valuable assets as we work to bring these innovative products to market," Fairley said. "An exciting aspect of this application for our business is that product development in the animal health sector can be faster than is usually associated with the development of human drugs."

The collaboration with Elanco is further demonstration of Starpharma's strong and successful partnership model and the multiple potential applications of its dendrimer technology. Starpharma also has partnerships with SSL International (Durex(R)), Siemens (Dade Behring), EMD Merck, Stiefel, Unilever, Qiagen and Sigma Aldrich.

Starpharma retains all rights to exploit the technology outside of Elanco's specific field of interest, including for all uses in humans, and continues to work to add to its portfolio of partners for drug delivery and dendrimer technology more widely.

In 2008, the global animal health market was reported to be about US$19 billion. Global sales are expected to reach US$21.7B by 2010, at which time the top three markets are forecast to be USA, China and Brazil, with the USA accounting for 40 percent of growth [1].

About Starpharma

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a world leader in the development of dendrimer nanotechnology for pharmaceutical, life-science and other applications. SPL has two operating companies, Starpharma Pty Ltd in Melbourne, Australia and DNT, Inc in the USA. Products based on SPL's dendrimer technology are already on the market in the form of diagnostic elements and laboratory reagents through licence arrangements with partners including Siemens and Merck KgA.

    For further information:

       Buchan Consulting
       Rebecca Wilson
       Tel: +61 3 9866 4722
       Mob: +61 417 382 391

       Ellie Papathanasiou
       Tel: +61 2 9237 2800

       Dr Jackie Fairley
       Chief Executive Officer
       +61 3 8532 2704

       Ben Rogers
       Company Secretary
       +61 3 8532 2702

[1]Vetnosis for global animal health market estimate; all other information in "World Animal Health Markets" from Informa Healthcare, January 2008.

SOURCE Starpharma
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Starpharma and Durex Sign Co-Development Agreement for VivaGel(R)-Coated Condoms
2. Heifer and Elanco Announce Charitable Partnership
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
5. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
6. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
7. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
8. RNs at Nine Catholic Healthcare West Hospitals Reach Agreement on New Master Pact
9. WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana
10. Biomoda, Inc. and Quintiles Announce Agreement for Regulatory Consulting
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Scott Newman MD, ... a select few plastic surgeons in the New York City area to utilize ... the world’s first heat-induced laser treatment for fat loss in the abdomen, flanks, ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... a leading provider of enterprise Time and Attendance/Workforce Management cloud-based solutions, announced ... Microsoft Partner Program with competencies in the Application Development, demonstrating a “best-in-class” ...
(Date:11/30/2015)... ... 30, 2015 , ... Workstation solutions provider , HealthPostures, ... dealers located throughout the United States, is OneStop Ergonomics. The addition allows HealthPostures ... and government workers and organizational leaders that are introduced to innovative methods that ...
(Date:11/30/2015)... ... November 30, 2015 , ... CTI Group (Holdings) ... empower organizations through communication analytics, announced today that their Proteus® VoIP QMS solution ... service quality. , Proteus® VoIP QMS (Quality Management System) does this ...
(Date:11/29/2015)... ... November 30, 2015 , ... The Cyber Monday deal is a deep 40% or ... right time to get gifts for the skin care lover in your circle. Each ... serums . This year, the 3 serums are staples: Collagen, Retinol and Hyaluronic Serums. , ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... the Six Months Ended 30 September 2015 2014RestatedChange%Turnover 545,575 , 518,852 ... , 384,242 , 9.8 Hospital Management ... , (18.3) Medical Insurance Administration Service Income , ... Medical Devices and Accessories Sales , 89,645 , ... 2,822 , 2,917 , (3.3) ...
(Date:11/30/2015)... 2015  Kevin Smith has been appointed Chief ... pioneer in wireless monitoring of vital signs.  As ... , Mr. Smith will be responsible for the ... He will also directly oversee partnering with US ... for SensiumVitals, the first early warning detection device ...
(Date:11/30/2015)... India , November 30, 2015 ... market research report "Dental Lasers Market by Product (Soft Tissue, ... Periodontitis), End User (Hospitals, Clinics), and Geography - Global Forecast ... 224.7 Million by 2020, at a CAGR of 5.2% during ... Browse 140 market data Tables and 62 Figures spread through ...
Breaking Medicine Technology: